Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Melanoma prevention: Do we need sunlight for vitamin D?

Prof Julia A Newton-Bishop - University of Leeds, Leeds, UK
Melanoma prevention: Do we need sunlight for vitamin D? ( Prof Julia A Newton-Bishop - University of Leeds, Leeds, UK )
5 Nov 2015

Why is screening for melanoma important?

Prof Iris Zalaudek - Medical University of Graz, Graz, Austria
Why is screening for melanoma important? ( Prof Iris Zalaudek - Medical University of Graz, Graz, Austria )
5 Nov 2015

Management of acute metastatic melanoma

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK
Management of acute metastatic melanoma ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )
5 Nov 2015

How should we handle talimogene laherparepvec (T-VEC)?

Prof Axel Hauschild - University of Kiel, Kiel, Germany
How should we handle talimogene laherparepvec (T-VEC)? ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
5 Nov 2015

New challenges in drug combination and strategies

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK
New challenges in drug combination and strategies ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )
5 Nov 2015

Editor's choice for October 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Editor's choice for October 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
4 Nov 2015

Targeting N-RAS mutated tumours

Prof Axel Hauschild - University of Kiel, Kiel, Germany
Targeting N-RAS mutated tumours ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
30 Oct 2015

HVEM expression in melanoma metastasis: prognosis correlation

Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France
HVEM expression in melanoma metastasis: prognosis correlation ( Prof Daniel Olive - Marseilles Cancer Research Center, Marseilles, France )
30 Oct 2015

Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma

Prof Axel Hauschild - University of Kiel, Kiel, Germany
Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )
30 Oct 2015

Cancer and the workplace

Dr Fiona Adshead - Chief Wellbeing & Public Health Officer, Bupa
Cancer and the workplace ( Dr Fiona Adshead - Chief Wellbeing & Public Health Officer, Bupa )
29 Oct 2015

How should decision makers assess the value of a medicine?

Dr Hans-Georg Eichler - Senior Medical Officer, European Medicines Agency
How should decision makers assess the value of a medicine? ( Dr Hans-Georg Eichler - Senior Medical Officer, European Medicines Agency )
29 Oct 2015

Lessening the global financial burden of cancer

Dr Christopher Wild - Director, International Agency for Research on Cancer, Lyon, France
Lessening the global financial burden of cancer ( Dr Christopher Wild - Director, International Agency for Research on Cancer, Lyon, France )
29 Oct 2015